News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
BlueRock Therapeutics, a clinical stage cell therapy company, and bit.bio, the company coding human cells for novel cures, have announced a collaboration and option agreement for the discovery and manufacture of iPSC-derived regulatory T cells (Tregs)...
Evox Therapeutics, an exosome therapeutics company, has announced a research collaboration and option agreement with the Icahn School of Medicine at Mount Sinai in New York, US.
A promising shift towards the development of antibody-drug conjugates (ADC) for cancer treatment is taking place in the pharmaceutical industry.